Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMC Medical Research Methodology|June 27, 2020
Comparison of methods for handling covariate missingness in propensity score estimation with a binary exposureDonna L Coffman, Jiangxiu Zhou, Xizhen Cai
Pharmaceutical Statistics|March 27, 2023
Quantification of follow-up time in oncology clinical trials with a time-to-event endpoint: Asking the right questionsKaspar Rufibach, Lynda Grinsted, Jiang Li, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|June 1, 2013
Random assignment of schools to groups in the drug resistance strategies rural project: some new methodological twistsJohn W Graham, Jonathan Pettigrew, Michelle Miller-Day, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand FrameworkEvgeny Degtyarev, Kaspar Rufibach, Yue Shentu, et al.
Pharmaceutical Statistics|October 4, 2021
Estimands for overall survival in clinical trials with treatment switching in oncologyJuliane Manitz, Natalia Kan-Dobrosky, Hannes Buchner, et al.
The New England Journal of Medicine|December 8, 2025
Dual Targeting of Extramedullary Myeloma with Talquetamab and TeclistamabShaji Kumar, María-Victoria Mateos, Jing Christine Ye, et al.
The New England Journal of Medicine|June 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory MyelomaRoberto Mina, Meral Beksac, Paula Rodríguez-Otero, et al.
Pageof 1